Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Yanzhong WangJin ZengWeiping WuShuduo XieHaitao YuGuoli LiTao ZhuFengying LiJie LuGavin Y WangXinyou XieJun ZhangPublished in: Breast cancer research : BCR (2019)
The results of this study demonstrate a novel correlation between the NNMT expression level and patient survival, suggesting that NNMT has the potential to become a new prognostic biomarker to predict the treatment outcomes of the clinical chemotherapy in breast cancer. Moreover, targeting NNMT or downstream SIRT1 may represent a new therapeutic approach to improve the efficacy of breast cancer chemotherapy.